MedTech Acquisition adjourns special meeting on TriSalus merger to Aug 8; redemption deadline extended to Aug 4

TriSalus Life Sciences, Inc.

Special meeting for TriSalus business combination adjourned to August 8, 2023 at 11:00 a.m. ET.
Vote to adjourn: 7,134,393 for, 1,777 against; quorum of 96.5% voting power present.
Redemption deadline for public stockholders extended to August 4, 2023 at 5:00 p.m. ET.
Prior to meeting, MTAC filed 8-K regarding FDA written response for TriSalus' PERIO-01 clinical program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.